Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound) [Yahoo! Finance]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance
of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency (EMA) regulations. The certification is a milestone for Kexing Biopharm, whose first drug for cancer therapy, Paclitaxel for Injection (Albumin Bound) , can now be registered in the EU as the company overcomes the primary obstacle and officially embarks on its journey into the EU pharmaceutical market. Since its initial public offering, Kexing Biopharm has actualized international strategies , focusing on high clinical value, a high technical level, high international quality management and registration standards, and fast commercializatio n to expand its portfolio to 13 products. Paclitaxel for Injection (Albumin Bound) is Kexing Biopharm's first drug for cancer therapy. The manufacturing of the drug requires production equipment of a higher level, technical expertise of an advanced level, incredibly stringent aseptic management of the lean manufa
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Avenacy Announces Launch of Isoproterenol Hydrochloride Injection, USP in the U.S. Market [Yahoo! Finance]Yahoo! Finance
- Regulatory Information Management System Market Report 2024-2030: Increasing Adoption of Centralized RIMS among the Pharmaceutical and Medical Device Industry - A USD 4.12 Billion Market by 2030 [Yahoo! Finance]Yahoo! Finance
- Asembia Brings Together Top Pharmacy Executives for 20th Summit; Hosting Cornerstone Conference Delivering Continued Collaboration and Connections [Yahoo! Finance]Yahoo! Finance
- CeraVe Expands Sun Safety Day Initiative, Offering SPF Education From Coast to Coast This Summer [Yahoo! Finance]Yahoo! Finance
- Leading Penang-based Healthcare Provider Bags Multiple Awards at the GlobalHealth Asia-Pacific Awards 2024 [Yahoo! Finance Canada]Yahoo! Finance Canada
IQV
Earnings
- 5/2/24 - Beat
IQV
Sec Filings
- 5/17/24 - Form 3
- 5/10/24 - Form 8-K
- 5/9/24 - Form 4
- IQV's page on the SEC website